Tinlarebant is a small molecule inhibitor of the farnesoid X receptor (FXR), a bile acid receptor modulator under investigation for the treatment of primary biliary cholangitis. This category features… Read more
Tinlarebant is a small molecule inhibitor of the farnesoid X receptor (FXR), a bile acid receptor modulator under investigation for the treatment of primary biliary cholangitis. This category features Tinlarebant alongside related chemical entities, including specific intermediates and precursors such as 4-(3,4-difluoro-2-(trifluoromethyl)phenyl)piperidine and relevant methanone derivatives. These compounds are essential for laboratories requiring accurate reference standards to support rigorous analytical testing and method validation throughout the drug development lifecycle. By utilizing these high-quality materials, researchers can perform precise impurity profiling and conduct robust pharmacokinetic studies to ensure compliance with quality control standards. Whether developing analytical methods for process monitoring or performing structural verification, these reference standards provide the necessary support for identifying and quantifying the active pharmaceutical ingredient and its associated synthesis-related compounds in various biological and chemical matrices.